Keywords: USA, Kohl-Grassley generics billl, Taxpayer savings, CBO report, Pay-for-delay deals

Kohl-Grassley generic drug bill would save US taxpayers nearly $4.8 billion, says CBO

Article | 09 November 2011

A new estimate from the USA’s Congressional Budget Office (CBO) estimate finds that a bipartisan bill aimed at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in